Loading...
Loading...
LIVN| Name | Value |
|---|---|
| Revenues | 352.5M |
| Cost of Revenue | 113.5M |
| Gross Profit | 239.0M |
| Operating Expense | 185.0M |
| Operating I/L | 54.2M |
| Other Income/Expense | -20.9M |
| Interest Income | 0.0M |
| Pretax | 33.3M |
| Income Tax Expense | 6.2M |
| Net Income/Loss | 27.2M |
LivaNova PLC is a global medical device company that generates revenue through the design, development, manufacturing, and sale of therapeutic solutions. The company operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment focuses on products such as oxygenators, heart-lung machines, autotransfusion systems, and perfusion tubing systems. The Neuromodulation segment markets the VNS Therapy System for drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. The Advanced Circulatory Support segment specializes in temporary life support products. LivaNova serves healthcare professionals and institutions through direct sales and independent distributors.
